scholarly journals Transcatheter Decellularized Tissue-Engineered Heart Valve (dTEHV) Grown on Polyglycolic Acid (PGA) Scaffold Coated with P4HB Shows Improved Functionality over 52 Weeks due to Polyether-Ether-Ketone (PEEK) Insert

2018 ◽  
Vol 9 (4) ◽  
pp. 64 ◽  
Author(s):  
Leon Bruder ◽  
Hendrik Spriestersbach ◽  
Kerstin Brakmann ◽  
Valentin Stegner ◽  
Matthias Sigler ◽  
...  
Keyword(s):  
Heart Valve ◽  
Second Generation ◽  
Heart Defects ◽  
Polyglycolic Acid ◽  
Elastic Fibers ◽  
Polyether Ether Ketone ◽  
Tissue Engineered Heart Valve ◽  
Ether Ketone ◽  
Decellularized Tissue

Many congenital heart defects and degenerative valve diseases require replacement of heart valves in children and young adults. Transcatheter xenografts degenerate over time. Tissue engineering might help to overcome this limitation by providing valves with ability for self-repair. A transcatheter decellularized tissue-engineered heart valve (dTEHV) was developed using a polyglycolic acid (PGA) scaffold. A first prototype showed progressive regurgitation after 6 months in-vivo due to a suboptimal design and misguided remodeling process. A new geometry was developed accordingly with computational fluid dynamics (CFD) simulations and implemented by adding a polyether-ether-ketone (PEEK) insert to the bioreactor during cultivation. This lead to more belly-shaped leaflets with higher coaptation areas for this second generation dTEHV. Valve functionality assessed via angiography, intracardiac echocardiography, and MRI proved to be much better when compared the first generation dTEHV, with preserved functionality up to 52 weeks after implantation. Macroscopic findings showed no thrombi or signs of acute inflammation. For the second generation dTEHV, belly-shaped leaflets with soft and agile tissue-formation were seen after explantation. No excessive leaflet shortening occurred in the second generation dTEHV. Histological analysis showed complete engraftment of the dTEHV, with endothelialization of the leaflets and the graft wall. Leaflets consisted of collagenous tissue and some elastic fibers. Adaptive leaflet remodeling was visible in all implanted second generation dTEHV, and most importantly no fusion between leaflet and wall was found. Very few remnants of the PGA scaffold were detected even 52 weeks after implantation, with no influence on functionality. By adding a polyether-ether-ketone (PEEK) insert to the bioreactor construct, a new geometry of PGA-scaffold based dTEHV could be implemented. This resulted in very good valve function of the implanted dTEHV over a period of 52 weeks.

scholarly journals Decellularized Tissue-Engineered Heart Valve Leaflets with Recellularization Potential

2013 ◽  
Vol 19 (5-6) ◽  
pp. 759-769 ◽  
Author(s):  
Zeeshan H. Syedain ◽  
Allison R. Bradee ◽  
Stefan Kren ◽  
Doris A. Taylor ◽  
Robert T. Tranquillo
Keyword(s):  
Heart Valve ◽  
Tissue Engineered Heart Valve ◽  
Decellularized Tissue

scholarly journals Peri-implant cartilage and bone histological changes following treatment of focal osteochondral defects in the femoral head with polyether ether ketone implants versus cobalt chromium molybdenum alloy implants: assessment in a goat model

2020 ◽  
Author(s):  
Zhiguo Yuan ◽  
Wei Zhang ◽  
Xiangchao Meng ◽  
Jue Zhang ◽  
Teng TengLong ◽  
...  
Keyword(s):  
Femoral Head ◽  
Osteochondral Defect ◽  
Osteochondral Defects ◽  
Cobalt Chromium ◽  
Cocrmo Alloy ◽  
Polyether Ether Ketone ◽  
Histological Score ◽  
Ether Ketone ◽  
Cobalt Chromium Molybdenum

Abstract Objective: This study aimed to quantitatively investigate the peri-implant histology of applying defect-size polyether ether ketone (PEEK) implant for the treatment of localized osteochondral defects in the femoral head and compared it with cobalt chromium molybdenum (CoCrMo) alloy implant.Methods: A femoral head osteochondral defect model was created in the left hips of goats (n=12). Defects were randomly treated by immediate placement of a PEEK (n=6) or CoCrMo implant (n=6). The un-operated right hip joints served as a control. Goats were sacrificed at 12 weeks. Periprosthetic cartilage quality was semi-quantitatively analyzed macroscopically and microscopically. Implant osseointegration was measured by micro-CT and histomorphometry.Results: The modified macroscopic articular evaluation score in the PEEK group was lower than that in the CoCrMo group (p<0.05), and the histological score of the periprosthetic and acetabular cartilage in the PEEK group was lower than that in the CoCrMo group (P<0.05). The mean bone-implant contact for PEEK implants was comparable with that for CoCrMo alloy implants at 12 weeks.Conclusions: A PEEK implant for the treatment of local osteochondral defect in the femoral head demonstrated effective fixation and superior in vivo cartilage protection compared with an identical CoCrMo alloy implant.

scholarly journals In vivo remodeling of a 3D-Bioprinted tissue engineered heart valve scaffold

Bioprinting ◽  
2019 ◽  
Vol 16 ◽  
pp. e00059 ◽  
Author(s):  
Eva L. Maxson ◽  
Melissa D. Young ◽  
Christopher Noble ◽  
Jason L. Go ◽  
Behnam Heidari ◽  
...  
Keyword(s):  
Heart Valve ◽  
Tissue Engineered Heart Valve

scholarly journals Celecoxib Impairs Heart Development via  Inhibiting Cyclooxygenase-2 Activity in Zebrafish Embryos

2011 ◽  
Vol 114 (2) ◽  
pp. 391-400 ◽  
Author(s):  
Dao-jie Xu ◽  
Ji-wen Bu ◽  
Shan-ye Gu ◽  
Yi-meng Xia ◽  
Jiu-lin Du ◽  
...  
Keyword(s):  
Myosin Heavy Chain ◽  
Heart Valve ◽  
Heavy Chain ◽  
Heart Development ◽  
Heart Defects ◽  
Cyclooxygenase 2 ◽  
Confocal Imaging ◽  
Marker Genes ◽  
Zebrafish Embryos

Background Celecoxib, a cyclooxygenase-2 inhibitor, is a commonly ingested drug that is used by some women during pregnancy. Although use of celecoxib is associated with increased cardiovascular risk in adults, its effect on fetal heart development remains unknown. Methods Zebrafish embryos were exposed to celecoxib or other relevant drugs from tailbud stage (10.3-72 h postfertilization). Heart looping and valve formation were examined at different developmental stages by in vivo confocal imaging. In addition, whole mount in situ hybridization was performed to examine drug-induced changes in the expression of heart valve marker genes. Results In celecoxib-treated zebrafish embryos, the heart failed to undergo normal looping and the heart valve was absent, causing serious blood regurgitation. Furthermore, celecoxib treatment disturbed the restricted expression of the heart valve markers bone morphogenetic protein 4 and versican-but not the cardiac chamber markers cardiac myosin light chain 2, ventricular myosin heavy chain, and atrial myosin heavy chain. These defects in heart development were markedly relieved by treatment with the cyclooxygenase-2 downstream product prostaglandin E2, and mimicked by the cyclooxygenase-2 inhibitor NS398, implying that celecoxib-induced heart defects were caused by the inhibition of cyclooxygenase-2 activity. Conclusions These findings provide the first in vivo evidence that celecoxib exposure impairs heart development in zebrafish embryos by inhibiting cyclooxygenase-2 activity.

CURRENT DEVELOPMENTS AND FUTURE CHALLENGES FOR THE CREATION OF AORTIC HEART VALVE

2008 ◽  
Vol 08 (01) ◽  
pp. 1-15 ◽  
Author(s):  
YOS S. MORSI ◽  
CYNTHIA S. WONG
Keyword(s):  
Heart Valve ◽  
Heart Valves ◽  
Mechanical Characteristics ◽  
Polyglycolic Acid ◽  
Cellular Interactions ◽  
Trimethylene Carbonate ◽  
The Creation ◽  
Tissue Engineered Heart Valves

The concept of tissue-engineered heart valves offers an alternative to current heart valve replacements that is capable of addressing shortcomings such as life-long administration of anticoagulants, inadequate durability, and inability to grow. Since tissue engineering is a multifaceted area, studies conducted have focused on different aspects such as hemodynamics, cellular interactions and mechanisms, scaffold designs, and mechanical characteristics in the form of both in vitro and in vivo investigations. This review concentrates on the advancements of scaffold materials and manufacturing processes, and on cell–scaffold interactions. Aside from the commonly used materials, polyglycolic acid and polylactic acid, novel polymers such as hydrogels and trimethylene carbonate-based polymers are being developed to simulate the natural mechanical characteristics of heart valves. Electrospinning has been examined as a new manufacturing technique that has the potential to facilitate tissue formation via increased surface area. The type of cells utilized for seeding onto the scaffolds is another factor to take into consideration; currently, stem cells are of great interest because of their potential to differentiate into various types of cells. Although extensive studies have been conducted, the creation of a fully functional heart valve that is clinically applicable still requires further investigation due to the complexity and intricacies of the heart valve.

scholarly journals In vivo functional assessment of a novel degradable metal and elastomeric scaffold-based tissue engineered heart valve

2019 ◽  
Vol 157 (5) ◽  
pp. 1809-1816 ◽  
Author(s):  
Garrett N. Coyan ◽  
Antonio D'Amore ◽  
Yasumoto Matsumura ◽  
Drake D. Pedersen ◽  
Samuel K. Luketich ◽  
...  
Keyword(s):  
Heart Valve ◽  
Functional Assessment ◽  
Tissue Engineered Heart Valve

scholarly journals Recellularization of decellularized heart valves: Progress toward the tissue-engineered heart valve

2017 ◽  
Vol 8 ◽  
pp. 204173141772632 ◽  
Author(s):  
Mitchell C VeDepo ◽  
Michael S Detamore ◽  
Richard A Hopkins ◽  
Gabriel L Converse
Keyword(s):  
Heart Valve ◽  
Heart Valves ◽  
Mechanical Conditioning ◽  
New Era ◽  
Processing Strategies ◽  
Tissue Engineered Heart Valve ◽  
Tissue Engineered Heart Valves

The tissue-engineered heart valve portends a new era in the field of valve replacement. Decellularized heart valves are of great interest as a scaffold for the tissue-engineered heart valve due to their naturally bioactive composition, clinical relevance as a stand-alone implant, and partial recellularization in vivo. However, a significant challenge remains in realizing the tissue-engineered heart valve: assuring consistent recellularization of the entire valve leaflets by phenotypically appropriate cells. Many creative strategies have pursued complete biological valve recellularization; however, identifying the optimal recellularization method, including in situ or in vitro recellularization and chemical and/or mechanical conditioning, has proven difficult. Furthermore, while many studies have focused on individual parameters for increasing valve interstitial recellularization, a general understanding of the interacting dynamics is likely necessary to achieve success. Therefore, the purpose of this review is to explore and compare the various processing strategies used for the decellularization and subsequent recellularization of tissue-engineered heart valves.

scholarly journals In vivo autologous recellularization of a tissue-engineered heart valve: Are bone marrow mesenchymal stem cells the best candidates?

2007 ◽  
Vol 134 (2) ◽  
pp. 424-432 ◽  
Author(s):  
Andre Vincentelli ◽  
Fabrice Wautot ◽  
Francis Juthier ◽  
Olivier Fouquet ◽  
Delphine Corseaux ◽  
...  
Keyword(s):  
Stem Cells ◽  
Bone Marrow ◽  
Mesenchymal Stem Cells ◽  
Heart Valve ◽  
Marrow Mesenchymal Stem Cells ◽  
Tissue Engineered Heart Valve
Sign in / Sign up

Export Citation Format

Share Document